新生儿早发型败血症抗生素合理使用的研究进展
Research Progress on Rational Use of Antibiotics in Neonatal Early-Onset Septicemia
DOI: 10.12677/ACM.2022.123300, PDF,   
作者: 陈丽萍, 包 蕾*:重庆医科大学附属儿童医院新生儿科,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,儿科学重庆市重点实验室,重庆
关键词: 新生儿早发型败血症抗生素Neonate Early-Onset Septicemia Antibiotics
摘要: 新生儿败血症是指新生儿期细菌或真菌侵入血液导致的全身炎症反应综合征,早发型败血症一般发病时间 ≤ 3日龄。尽管这些年我国在新生儿管理方面获得了很大的进步,但新生儿早发型败血症仍然是新生儿发病和死亡的主要原因之一,尤其是早产儿和低出生体重儿。抗生素的治疗有效地降低了其死亡率,同时抗生素的不合理使用也可能带来不良预后,如新生儿坏死性小肠结肠炎、晚发型败血症、死亡等,故对新生儿早发型败血症进行合理的抗生素治疗显得尤为重要。下文将对新生儿早发型败血症的抗生素使用方面的研究进行探讨。
Abstract: Neonatal septicemia refers to the systemic inflammatory response syndrome caused by bacteria or fungi invading the blood during the neonatal period. The general onset time of early-onset septicemia is less than 3 days old. Although China has made great progress in neonatal management in recent years, neonatal early-onset septicemia is still one of the main causes of neonatal morbidity and death, especially of the premature and low birth weight infants. The treatment of antibiotics can effectively reduce the mortality rate. But the unreasonable use of antibiotics may also lead to poor prognosis, such as neonatal necrotizing enterocolitis, late-onset septicemia, death and so on. Therefore, reasonable antibiotic treatment of neonatal early-onset septicemia is particularly important. The following study will discuss the use of antibiotics in neonatal early-onset septicemia.
文章引用:陈丽萍, 包蕾. 新生儿早发型败血症抗生素合理使用的研究进展[J]. 临床医学进展, 2022, 12(3): 2092-2097. https://doi.org/10.12677/ACM.2022.123300

参考文献

[1] 李明阳, 等. 2000-2017年中国5岁以下儿童死亡率变化趋势及死因研究[J]. 现代预防医学, 2021, 48(3): 389-392+397.
[2] Polin, R.A. (2012) Management of Neonates with Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics, 129, 1006-1015.
[Google Scholar] [CrossRef] [PubMed]
[3] Mueller, N.T., et al. (2005) Prenatal Exposure to Antibiotics, Cesarean Section and Risk of Childhood Obesity. International Journal of Obesity, 39, 665-670.
[Google Scholar] [CrossRef] [PubMed]
[4] Stensballe, L.G.M.P., et al. (2013) Use of Antibiotics during Pregnancy Increases the Risk of Asthma in Early Childhood. The Journal of Pediatrics, 162, 832-838.e3.
[Google Scholar] [CrossRef] [PubMed]
[5] Zwittink, R.D., et al. (2018) Association between Duration of Intravenous Antibiotic Administration and Early-Life Microbiota Development in Late-Preterm Infants. European Journal of Clinical Microbiology & Infectious Diseases, 37, 475-483.
[Google Scholar] [CrossRef] [PubMed]
[6] Esaiassen, E., et al. (2017) Antibiotic Exposure in Neonates and Early Adverse Outcomes: A Systematic Review and Meta-Analysis. Journal of Antimicrobial Chemotherapy, 72, 1858-1870.
[Google Scholar] [CrossRef] [PubMed]
[7] Cantey, J.B. and Sanchez, P.J. (2018) Early Antibiotic Exposure and Adverse Outcomes in Preterm, Very Low Birth Weight Infants. The Journal of Pediatrics, 203, 62-67.
[Google Scholar] [CrossRef] [PubMed]
[8] Rodríguez Osiac, L. and Pizarro Quevedo, T. (2018) Prolonged Initial Empirical Antibiotic Treatment and the Risk of Morbidity and Mortality in Very Low Birthweight Infants. Revista Chilena de Pediatria, 89, 600-605.
[Google Scholar] [CrossRef
[9] Fajardo, C., Alshaikh, B. and Harabor, A. (2019) Prolonged Use of Antibiotics after Birth Is Associated with Increased Morbidity in Preterm Infants with Negative Cultures. The Journal of Maternal-Fetal & Neonatal Medicine, 32, 4060-4066.
[Google Scholar] [CrossRef] [PubMed]
[10] Pott, J., et al. (2012) Age-Dependent TLR3 Expression of the Intestinal Epithelium Contributes to Rotavirus Susceptibility. PLoS Pathogens, 8, e1002670.
[Google Scholar] [CrossRef] [PubMed]
[11] Sanidad, K.Z. and Zeng, M.Y. (2020) Neonatal Gut Microbiome and Immunity. Current Opinion in Microbiology, 56, 30-37.
[Google Scholar] [CrossRef] [PubMed]
[12] Sorsa, A. (2019) Epidemiology of Neonatal Sepsis and Associated Factors Implicated: Observational Study at Neonatal Intensive Care Unit of Arsi University Teaching and Referral Hospital, South East Ethiopia. Ethiopian Journal of Health Sciences, 29, 333-342.
[Google Scholar] [CrossRef] [PubMed]
[13] Greenberg, R.G., et al. (2017) Late-Onset Sepsis in Extremely Premature Infants: 2000-2011. The Pediatric Infectious Disease Journal, 36, 774-779.
[Google Scholar] [CrossRef
[14] Camargo, J.F., Caldas, J. and Marba, S. (2021) Early Neonatal Sepsis: Prevalence, Complications and Outcomes in Newborns with 35 Weeks of Gestational Age or More. Revista Paulista de Pediatria, 40, e2020388.
[Google Scholar] [CrossRef] [PubMed]
[15] Shane, A.L.D., Sanchez, P.J.P. and Stoll, B.J.P. (2017) Neonatal Sepsis. The Lancet (British Edition), 390, 1770-1780.
[Google Scholar] [CrossRef
[16] Schmatz, M., et al. (2020) Surviving Sepsis in a Referral Neonatal Intensive Care Unit: Association between Time to Antibiotic Administration and In-Hospital Outcomes. The Journal of Pediatrics, 217, 59-65.e1.
[Google Scholar] [CrossRef] [PubMed]
[17] Romano-Keeler, J. and Weitkamp, J.H. (2015) Maternal Influences on Fetal Microbial Colonization and Immune Development. Pediatric Research, 77, 189-195.
[Google Scholar] [CrossRef] [PubMed]
[18] Neu, J. (2016) The Microbiome during Pregnancy and Early Postnatal Life. Seminars in Fetal & Neonatal Medicine, 21, 373-379.
[Google Scholar] [CrossRef] [PubMed]
[19] Salvatore, S., et al. (2019) Neonatal Antibiotics and Prematurity Are Associated with an Increased Risk of Functional Gastrointestinal Disorders in the First Year of Life. The Journal of Pediatrics, 212, 44-51.
[Google Scholar] [CrossRef] [PubMed]
[20] Ting, J.Y. (2018) Association of Antibiotic Utilization and Neurodevelopmental Outcomes among Extremely Low Gestational Age Neonates without Proven Sepsis or Necrotizing Enterocolitis.
[Google Scholar] [CrossRef] [PubMed]
[21] Cordero, L. and Ayers, L.W. (2003) Duration of Empiric Antibiotics for Suspected Early-Onset Sepsis in Extremely Low Birth Weight Infants. Infection Control & Hospital Epidemiology, 24, 662-666.
[Google Scholar] [CrossRef] [PubMed]
[22] Ting, J.Y., et al. (2019) Duration of Initial Empirical Antibiotic Therapy and Outcomes in Very Low Birth Weight Infants. Pediatrics, 143, e20182286.
[Google Scholar] [CrossRef] [PubMed]
[23] Cotten, C.M., et al. (2009) Prolonged Duration of Initial Empirical Antibiotic Treatment Is Associated with Increased Rates of Necrotizing Enterocolitis and Death for Extremely Low Birth Weight Infants. Pediatrics, 123, 58-66.
[Google Scholar] [CrossRef] [PubMed]
[24] Cantey, J.B.M., et al. (2016) Antibiotic Exposure and Risk for Death or Bronchopulmonary Dysplasia in Very Low Birth Weight Infants. The Journal of Pediatrics, 181, 289-293.e1.
[Google Scholar] [CrossRef] [PubMed]
[25] Mermel, L.A., et al. (2009) Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 49, 1-45.
[Google Scholar] [CrossRef] [PubMed]
[26] Hemels, M.A., et al. (2012) Shortening the Antibiotic Course for the Treatment of Neonatal Coagulase-Negative Staphylococcal Sepsis: Fine with Three Days? Neonatology, 101, 101-105.
[Google Scholar] [CrossRef] [PubMed]
[27] Rohatgi, S., et al. (2017) Seven versus 10 Days Antibiotic Therapy for Culture-Proven Neonatal Sepsis: A Randomised Controlled Trial. Journal of Paediatrics and Child Health, 53, 556-562.
[Google Scholar] [CrossRef] [PubMed]
[28] Yahav, D. (2019) Seven versus Fourteen Days of Antibiotic Therapy for Uncomplicated Gram-Negative Bacteremia: A Non-Inferiority Randomized Controlled Trial.
[29] Reddy, A., et al. (2021) Ten versus 14 Days of Antibiotic Therapy in Culture-Proven Neonatal Sepsis: A Randomized, Controlled Trial. Indian Journal of Pediatrics.
[Google Scholar] [CrossRef] [PubMed]
[30] 新生儿败血症诊断及治疗专家共识(2019年版) [J]. 中华儿科杂志, 2019, 57(4): 252-257.
[31] Gyllensvard, J., et al. (2020) C-Reactive Protein- and Clinical Symptoms-Guided Strategy in Term Neonates with Early-Onset Sepsis Reduced Antibiotic Use and Hospital Stay: A Quality Improvement Initiative. BMC Pediatrics, 20, Article No. 531.
[Google Scholar] [CrossRef] [PubMed]
[32] Stocker, M., et al. (2017) Procalcitonin-Guided Decision Making for Duration of Antibiotic Therapy in Neonates with Suspected Early-Onset Sepsis: A Multicentre, Randomised Controlled Trial (NeoPIns). The Lancet (British Edition), 390, 871-881.
[33] Isaacs, D., Wilkinson, A.R. and Moxon, E.R. (1987) Duration of Antibiotic Courses for Neonates. Archives of Disease in Childhood, 62, 727-728.
[Google Scholar] [CrossRef] [PubMed]
[34] Kaiser, J.R., Cassat, J.E. and Lewno, M.J. (2002) Should Antibiotics Be Discontinued at 48 Hours for Negative Late-Onset Sepsis Evaluations in the Neonatal Intensive Care Unit? Journal of Perinatology, 22, 445-447.
[Google Scholar] [CrossRef] [PubMed]
[35] Zingg, W., et al. (2011) Secular Trends in Antibiotic Use among Neonates: 2001-2008. The Pediatric Infectious Disease Journal, 30, 365-370.
[Google Scholar] [CrossRef
[36] Rueda, M.S., et al. (2019) Antibiotic Overuse in Premature Low Birth Weight Infants in a Developing Country. The Pediatric Infectious Disease Journal, 38, 302-307.
[Google Scholar] [CrossRef